| Market Size in 2023 | Market Forecast in 2032 | CAGR (in %) | Base Year |
|---|---|---|---|
| USD 399.08 Million | USD 698.66 Million | 6.42% | 2023 |
FrequentlyAsked Questions
Bioabsorbable stents are medical devices used to treat narrowed or blocked blood vessels, which are designed to be gradually absorbed by the body over time.
According to study, the Bioabsorbable Stents Market size was worth around USD 399.08 million in 2023 and is predicted to grow to around USD 698.66 million by 2032.
The CAGR value of Bioabsorbable Stents Market is expected to be around 6.42% during 2024-2032.
Europe and North America has been leading the Bioabsorbable Stents Market and is anticipated to continue on the dominant position in the years to come.
The Bioabsorbable Stents Market is led by players like Medtronic Plc, Abbott Laboratories, Biotronik SE & Co. KG, STENTYS SA, Microport Scientific Corporation, B. Braun Melsungen AG, Boston Scientific Corporation, Terumo Corporation, Elixir Medical Corporation, and C.R. Bard, Inc. amongst others.
HappyClients